Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP
In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding
Univ. Of Pittsburg distances Itself From Fisher
Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths
A Transcript: what Fisher Knew, When Did He Know
NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
